AR102666A1 - Método para tratar, prevenir, o reducir el riesgo de infección de la piel, formulación y uso - Google Patents
Método para tratar, prevenir, o reducir el riesgo de infección de la piel, formulación y usoInfo
- Publication number
- AR102666A1 AR102666A1 ARP150103729A ARP150103729A AR102666A1 AR 102666 A1 AR102666 A1 AR 102666A1 AR P150103729 A ARP150103729 A AR P150103729A AR P150103729 A ARP150103729 A AR P150103729A AR 102666 A1 AR102666 A1 AR 102666A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- nr4r4
- nr4c
- unsaturated
- aromatic
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 206010040872 skin infection Diseases 0.000 title abstract 3
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 22
- 125000003118 aryl group Chemical group 0.000 abstract 19
- 229910052760 oxygen Inorganic materials 0.000 abstract 13
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 12
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 11
- 125000005842 heteroatom Chemical group 0.000 abstract 11
- 229910052757 nitrogen Inorganic materials 0.000 abstract 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 11
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 11
- 239000001301 oxygen Chemical group 0.000 abstract 11
- 229910052717 sulfur Chemical group 0.000 abstract 11
- 239000011593 sulfur Chemical group 0.000 abstract 11
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 6
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 abstract 5
- 125000000623 heterocyclic group Chemical group 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 3
- 241000186427 Cutibacterium acnes Species 0.000 abstract 2
- 241000207201 Gardnerella vaginalis Species 0.000 abstract 2
- 241000191967 Staphylococcus aureus Species 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 230000001404 mediated effect Effects 0.000 abstract 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 229940002612 prodrug Drugs 0.000 abstract 2
- 239000000651 prodrug Substances 0.000 abstract 2
- 229940055019 propionibacterium acne Drugs 0.000 abstract 2
- 125000003373 pyrazinyl group Chemical group 0.000 abstract 2
- 125000002098 pyridazinyl group Chemical group 0.000 abstract 2
- 125000004076 pyridyl group Chemical group 0.000 abstract 2
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 abstract 1
- BSFODEXXVBBYOC-UHFFFAOYSA-N 8-[4-(dimethylamino)butan-2-ylamino]quinolin-6-ol Chemical group C1=CN=C2C(NC(CCN(C)C)C)=CC(O)=CC2=C1 BSFODEXXVBBYOC-UHFFFAOYSA-N 0.000 abstract 1
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 229910006074 SO2NH2 Inorganic materials 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 abstract 1
- 239000012049 topical pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462080212P | 2014-11-14 | 2014-11-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR102666A1 true AR102666A1 (es) | 2017-03-15 |
Family
ID=55955188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150103729A AR102666A1 (es) | 2014-11-14 | 2015-11-16 | Método para tratar, prevenir, o reducir el riesgo de infección de la piel, formulación y uso |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US10471046B2 (https=) |
| EP (1) | EP3217974A4 (https=) |
| JP (1) | JP2017534654A (https=) |
| KR (1) | KR20170084200A (https=) |
| CN (1) | CN107205989A (https=) |
| AR (1) | AR102666A1 (https=) |
| AU (1) | AU2015346023A1 (https=) |
| BR (1) | BR112017009989A2 (https=) |
| CA (1) | CA2967825A1 (https=) |
| CL (1) | CL2017001245A1 (https=) |
| CR (1) | CR20170196A (https=) |
| EA (1) | EA201791051A1 (https=) |
| HK (1) | HK1244211A1 (https=) |
| IL (1) | IL252197A0 (https=) |
| MX (1) | MX389005B (https=) |
| NI (1) | NI201700057A (https=) |
| PH (1) | PH12017500887A1 (https=) |
| SG (1) | SG11201703856VA (https=) |
| SV (1) | SV2017005444A (https=) |
| UY (1) | UY36402A (https=) |
| WO (1) | WO2016077818A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20180011843A (ko) | 2015-06-11 | 2018-02-02 | 바실리어 파마슈티카 인터내셔널 리미티드 | 유출-펌프 억제제 및 이의 치료적 용도 |
| AU2017371353B2 (en) * | 2016-12-09 | 2022-02-03 | Celltaxis, Llc | Monamine and monoamine derivatives as inhibitors of leukotriene A4 hydrolase |
| CN107721943A (zh) * | 2017-10-26 | 2018-02-23 | 沈阳药科大学 | 含联芳基腙结构的噁唑烷酮类化合物及其制备方法 |
| KR20190130243A (ko) | 2018-05-14 | 2019-11-22 | (주)텔리언 | 트러스트 인덱스를 이용한 공유경제 시스템 및 방법 |
| PL3992177T3 (pl) | 2019-06-25 | 2024-08-26 | Amtixbio Co., Ltd. | Nowatorska pochodna kwasu aminoalkanowego, zawierająca w swojej strukturze ugrupowanie bifenylowe, oraz kompozycja farmaceutyczna o działaniu przeciwgrzybiczym, w skład której wchodzi ta pochodna |
| CN115677679A (zh) * | 2021-07-26 | 2023-02-03 | 沈阳药科大学 | 含联芳基腙结构的噁唑烷酮化合物及其制备方法和应用 |
| CN120794967A (zh) * | 2024-04-10 | 2025-10-17 | 沈阳药科大学 | 联芳基噁唑烷酮类化合物及其应用 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES332272A1 (es) | 1965-10-20 | 1967-11-16 | Milwaukee Chaplet & Mfg Company Inc | Un dispositivo regulador de programa. |
| GB1185685A (en) | 1966-01-11 | 1970-03-25 | Quinoderm Ltd | Method of Making Pharmaceutical Compositions |
| US3418055A (en) | 1967-04-03 | 1968-12-24 | Schwartzman Gilbert | Pressure operated applicator and cap construction |
| US3410645A (en) | 1967-05-08 | 1968-11-12 | Schwartzman Gilbert | Concave diaphragm applicator |
| US3535422A (en) | 1968-03-11 | 1970-10-20 | Stiefel Laboratories | Stable benzoyl peroxide composition |
| US3669323A (en) | 1969-12-12 | 1972-06-13 | American Can Co | One-way valve insert for collapsible dispensing containers |
| US4056611A (en) | 1973-04-16 | 1977-11-01 | Stiefel Laboratories, Inc. | Therapeutic composition |
| GB1541463A (en) | 1975-10-11 | 1979-02-28 | Lion Dentifrice Co Ltd | Process for prparing a multiple emulsion having a dispersing form of water-phase/oil-phase/water-phase |
| US4620648A (en) | 1982-07-06 | 1986-11-04 | Dab-O-Matic Corp. | Pressure-responsive valve |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4985459A (en) | 1984-02-08 | 1991-01-15 | Richardson-Vicks, Inc. | Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same |
| US4693623A (en) | 1984-03-02 | 1987-09-15 | Dab-O-Matic Corp. | Pressure-responsive valve for an applicator |
| US4999186A (en) | 1986-06-27 | 1991-03-12 | The Procter & Gamble Company | Novel sunscreen agents, sunscreen compositions and methods for preventing sunburn |
| US4937370A (en) | 1987-06-02 | 1990-06-26 | The Procter & Gamble Company | Novel chromophores, sunscreen compositions and methods for preventing sunburn |
| US4960764A (en) | 1987-03-06 | 1990-10-02 | Richardson-Vicks Inc. | Oil-in-water-in-silicone emulsion compositions |
| US4800197A (en) | 1987-07-17 | 1989-01-24 | Richardson-Vicks Inc. | Anti-acne composition |
| US4891228A (en) | 1988-02-02 | 1990-01-02 | Richardson-Vicks Inc. | Medicated cleansing pads |
| US4891227A (en) | 1988-02-02 | 1990-01-02 | Richardson-Vicks Inc. | Medicated cleansing pads |
| US4919934A (en) | 1989-03-02 | 1990-04-24 | Richardson-Vicks Inc. | Cosmetic sticks |
| US5087445A (en) | 1989-09-08 | 1992-02-11 | Richardson-Vicks, Inc. | Photoprotection compositions having reduced dermal irritation |
| US5073371A (en) | 1990-11-30 | 1991-12-17 | Richardson-Vicks, Inc. | Leave-on facial emulsion compositions |
| US5073372A (en) | 1990-11-30 | 1991-12-17 | Richardson-Vicks, Inc. | Leave-on facial emulsion compositions |
| ATE146783T1 (de) | 1991-11-01 | 1997-01-15 | Upjohn Co | Substituierte aryl- und heteroaryl- phenyloxazolidinone |
| US5688792A (en) | 1994-08-16 | 1997-11-18 | Pharmacia & Upjohn Company | Substituted oxazine and thiazine oxazolidinone antimicrobials |
| WO1996030377A1 (en) | 1995-03-27 | 1996-10-03 | Isis Pharmaceuticals, Inc. | Nitrogenous macrocyclic compounds |
| ES2169811T3 (es) | 1995-09-22 | 2002-07-16 | Wakunaga Pharma Co Ltd | Nuevos derivados del acido piridonacarboxilico o sus sales y agente antibacteriano que comprende el mismo como ingrediente activo. |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| US6413981B1 (en) | 1999-08-12 | 2002-07-02 | Ortho-Mcneil Pharamceutical, Inc. | Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
| BR0111280A (pt) | 2000-06-05 | 2003-06-10 | Dong A Pharm Co Ltd | Novos derivados de oxazolidinona e um processo para a preparação dos mesmos |
| US20130059774A1 (en) * | 2000-08-01 | 2013-03-07 | Mahesh Vithalbhai Patel | Efflux pump inhibitors |
| US20030096850A1 (en) * | 2001-10-11 | 2003-05-22 | Ford Charles W. | Treating infections by administration of oxazolidinones |
| AR043050A1 (es) | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos |
| CN1780846A (zh) | 2003-03-05 | 2006-05-31 | Rib－X医药品有限公司 | 双官能杂环化合物及其制备和使用方法 |
| CN101429170B (zh) | 2003-06-03 | 2015-05-13 | 梅林塔医疗有限公司 | 联芳基杂环化合物的制备和用途 |
| JP5043428B2 (ja) * | 2003-06-03 | 2012-10-10 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | ビアリール複素環式化合物ならびにその製造および使用方法 |
| EP1660465B1 (en) | 2003-07-29 | 2014-12-17 | Melinta Therapeutics, Inc. | Process for the synthesis of biaryl oxazolidinones |
| WO2005012270A2 (en) | 2003-07-29 | 2005-02-10 | Rib-X Pharmaceuticals, Inc. | Biaryl heterocyclic amines, amides, and sulfur-containing compounds and methods of making and using the same |
| AR046782A1 (es) | 2003-12-17 | 2005-12-21 | Rib X Pharmaceuticals Inc | Compuestos heterociclicos de biarilo halogenados, composiciones farmaceuticas que los contienen, metodos para su elaboracion y su uso como medicamentos. |
| JP2008508271A (ja) | 2004-07-28 | 2008-03-21 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | ビアリール複素環式化合物ならびにその化合物を製造および使用する方法 |
| EP2816033A1 (en) | 2004-07-30 | 2014-12-24 | Abbvie Inc. | Preparation of pyridonecarboxylic acid antibacterials |
| US7728143B2 (en) | 2004-10-08 | 2010-06-01 | Abbott Laboratories | Salt and crystalline forms thereof of a drug |
| WO2006110815A1 (en) | 2005-04-11 | 2006-10-19 | Abbott Laboratories | Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs |
| DE602006019870D1 (de) | 2005-06-08 | 2011-03-10 | Rib X Pharmaceuticals Inc | Verfahren zur synthese von triazolen |
| EP3290427A1 (en) | 2005-08-24 | 2018-03-07 | Melinta Therapeutics, Inc. | Triazole compounds and methods of making and using the same |
| JP2009506063A (ja) | 2005-08-24 | 2009-02-12 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
| WO2011139832A2 (en) * | 2010-04-28 | 2011-11-10 | Rib-X Pharmaceuticals, Inc. | Method for treating mycobacterial infections |
-
2015
- 2015-11-16 HK HK18103723.8A patent/HK1244211A1/zh unknown
- 2015-11-16 CR CR20170196A patent/CR20170196A/es unknown
- 2015-11-16 SG SG11201703856VA patent/SG11201703856VA/en unknown
- 2015-11-16 US US14/942,021 patent/US10471046B2/en active Active
- 2015-11-16 EA EA201791051A patent/EA201791051A1/ru unknown
- 2015-11-16 AU AU2015346023A patent/AU2015346023A1/en not_active Abandoned
- 2015-11-16 JP JP2017525909A patent/JP2017534654A/ja not_active Withdrawn
- 2015-11-16 UY UY0001036402A patent/UY36402A/es not_active Application Discontinuation
- 2015-11-16 CA CA2967825A patent/CA2967825A1/en active Pending
- 2015-11-16 EP EP15858675.0A patent/EP3217974A4/en active Pending
- 2015-11-16 KR KR1020177015770A patent/KR20170084200A/ko not_active Withdrawn
- 2015-11-16 WO PCT/US2015/060851 patent/WO2016077818A1/en not_active Ceased
- 2015-11-16 MX MX2017006319A patent/MX389005B/es unknown
- 2015-11-16 BR BR112017009989-6A patent/BR112017009989A2/pt not_active Application Discontinuation
- 2015-11-16 CN CN201580073501.5A patent/CN107205989A/zh not_active Withdrawn
- 2015-11-16 AR ARP150103729A patent/AR102666A1/es unknown
-
2017
- 2017-05-10 IL IL252197A patent/IL252197A0/en unknown
- 2017-05-12 NI NI201700057A patent/NI201700057A/es unknown
- 2017-05-12 PH PH12017500887A patent/PH12017500887A1/en unknown
- 2017-05-15 CL CL2017001245A patent/CL2017001245A1/es unknown
- 2017-05-15 SV SV2017005444A patent/SV2017005444A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3217974A4 (en) | 2018-07-25 |
| EA201791051A1 (ru) | 2018-01-31 |
| CN107205989A (zh) | 2017-09-26 |
| US20160136137A1 (en) | 2016-05-19 |
| EP3217974A1 (en) | 2017-09-20 |
| CL2017001245A1 (es) | 2018-02-09 |
| SG11201703856VA (en) | 2017-06-29 |
| UY36402A (es) | 2016-06-30 |
| US10471046B2 (en) | 2019-11-12 |
| WO2016077818A1 (en) | 2016-05-19 |
| SV2017005444A (es) | 2017-08-31 |
| KR20170084200A (ko) | 2017-07-19 |
| AU2015346023A1 (en) | 2017-06-01 |
| JP2017534654A (ja) | 2017-11-24 |
| NI201700057A (es) | 2017-09-04 |
| IL252197A0 (en) | 2017-07-31 |
| PH12017500887A1 (en) | 2017-11-06 |
| CA2967825A1 (en) | 2016-05-19 |
| HK1244211A1 (zh) | 2018-08-03 |
| CR20170196A (es) | 2017-07-10 |
| MX2017006319A (es) | 2017-08-10 |
| BR112017009989A2 (pt) | 2018-01-02 |
| MX389005B (es) | 2025-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR102666A1 (es) | Método para tratar, prevenir, o reducir el riesgo de infección de la piel, formulación y uso | |
| ECSP21039272A (es) | Composición de control de organismos nocivos y método para usar la misma | |
| DOP2017000310A (es) | Inhibidores de metalo-beta-lactamasa | |
| AR116283A1 (es) | Inhibidores del sarcómero cardíaco | |
| AR094966A1 (es) | Composiciones farmacéuticas para el tratamiento de infecciones hcv | |
| CR20210477A (es) | Compuestos de aza-benzotiofeno y aza-benzofurano como antihelmínticos | |
| AR102492A1 (es) | Cromanos sustituidos y métodos para su uso | |
| AR045690A1 (es) | Compuestos biaril heterociclicos y metodos para preparar y utilizar los mismos | |
| AR123285A1 (es) | Compuestos heteroarílicos sustituidos útiles como inhibidores de tlr9 | |
| CR20200148A (es) | Compuestos monobactámicos cromados para el tratamiento de infecciones bacterianas | |
| AR123284A1 (es) | Compuestos heteroarílicos sustituidos útiles como inhibidores de tlr9 | |
| AR097199A1 (es) | Inhibidores de rorc2 y sus métodos de uso | |
| AR100191A1 (es) | Método para tratar adenocarcinoma de pulmón | |
| CO2019004978A2 (es) | Compuestos terapéuticos y métodos para utilizarlos | |
| AR117030A1 (es) | Composiciones que comprenden herbicidas de carboxilato de piridina con herbicidas inhibidores de la pds | |
| CL2017000839A1 (es) | Espiroindolinas para el tratamiento y profilaxis de infección por virus respiratorio sincitial (rsv) | |
| AR115906A1 (es) | Derivados de haloalilamina sulfona como inhibidores de lisil oxidasas | |
| BR112019024549A2 (pt) | compostos derivados de glicopeptídeo e usos dos mesmos | |
| ECSP22073580A (es) | Compuesto de oxazolidinona y métodos de uso de este como agente antibacteriano | |
| AR126892A1 (es) | Compuestos de aminopiridina sustituidos como inhibidores de egfr | |
| JP2019065009A5 (https=) | ||
| AR095895A1 (es) | Compuestos de acil-imino-piridina n-sustituidos y derivados para combatir plagas de animales | |
| CO2021018154A2 (es) | Compuestos y métodos de uso de los mismos como agentes antibacterianos | |
| AR084400A1 (es) | Compuestos de hetaril(tio)carboxamida para controlar plagas de invertebrados | |
| AR110481A1 (es) | MODULADORES DE ROR g (RORg) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |